Ziyun Liu

Tianjin, 300381, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Atmospheric versus soil Cadmium exposure in rice (Oryza sativa L.): Divergent toxicological mechanisms and human health risks via integrated multi-omics.

Atmospheric versus soil Cadmium exposure in rice (Oryza sativa L.): Divergent toxicological mechanisms and human health risks via integrated multi-omics.

Journal: Journal of hazardous materials
Published: May 16, 2026

Pan-cancer perspectives on post-translational modifications and metastasis: Unraveling complex molecular mechanisms.

Pan-cancer perspectives on post-translational modifications and metastasis: Unraveling complex molecular mechanisms.

Journal: Critical reviews in oncology/hematology
Published: November 26, 2025

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Journal: Cancer discovery
Published: September 18, 2025

The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment That Drives Tumor Radioresistance.

The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment That Drives Tumor Radioresistance.

Journal: Cancer research
Published: August 24, 2025

Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer.

Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer.

Journal: Molecular biomedicine
Published: July 09, 2025

Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer.

Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 02, 2025

The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer.

The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer.

Journal: Genomics
Published: March 25, 2025

Deciphering the interaction between the expression of LRP2 served as a mitochondrial metabolism-related gene and prognosis in colon cancer integrating multi-omics analysis.

Deciphering the interaction between the expression of LRP2 served as a mitochondrial metabolism-related gene and prognosis in colon cancer integrating multi-omics analysis.

Journal: Discover oncology
Published: November 05, 2024

DLL4-targeted CAR-T therapy sensitizes neoadjuvant chemotherapy via eliminating cancer stem cells and reshaping immune microenvironment in HER2+ breast cancer.

DLL4-targeted CAR-T therapy sensitizes neoadjuvant chemotherapy via eliminating cancer stem cells and reshaping immune microenvironment in HER2+ breast cancer.

Journal: Journal for immunotherapy of cancer
Published: October 18, 2024

The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma.

The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma.

Journal: Genomics
Published: April 10, 2024

Deciphering the composition and key driver genes of breast invasive micropapillary carcinoma by multi-omics analysis.

Deciphering the composition and key driver genes of breast invasive micropapillary carcinoma by multi-omics analysis.

Journal: iScience
Published: April 07, 2024

CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells.

CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells.

Journal: Gut
Published: March 08, 2024
Showing 1-12 of 21

Last Updated: 09/26/2026